Home › Funds › Gladius Capital Management LP › ABBV

Gladius Capital Management LP position in ABBV

ABBVIE INC · Health Care

Gladius Capital Management LP reported holding 70,000 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$18.3M, representing 1.30% of its reported portfolio and ranking #19 among its reported holdings. Gladius Capital Management LP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)70.00K sh
Reported value held$18.31M
Portfolio Weight1.30%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Gladius Capital Management LP's ABBV position evolved

Gladius Capital Management LP first disclosed a stake in ABBV in Q3 2023 at 8,844 shares (US$1.3M). The position peaked in Q3 2026 at 70,000 shares, worth US$18.3M. Across 13 filings, Gladius Capital Management LP increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 70,000 shares valued at US$18.3M — an increase of 22,900 shares quarter over quarter.. Notable position changes include a 79% trim in Q2 2025 (shares rose 26% over the following quarter), a 1196% increase in Q3 2025 (shares were roughly flat over the following quarter), a 1100% increase in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 8.84K $1.32M New
Q4 2023 9.70K $1.50M Add
Q1 2024 2.44K $444.87K Reduce
Q2 2024 4.24K $727.42K Add
Q3 2024 6.39K $1.26M Add
Q4 2024 9.06K $1.61M Add
Q1 2025 5.47K $1.15M Reduce
Q2 2025 1.17K $217.73K Reduce
Q3 2025 15.20K $3.52M Add
Q4 2025 7.57K $1.73M Reduce
Q1 2026 3.92K $853.65K Reduce
Q2 2026 47.10K $11.85M Add
Q3 2026 70.00K $18.31M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Gladius Capital Management LP held ABBV?

Gladius Capital Management LP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Gladius Capital Management LP's current position in ABBV?

As of Q3 2026, Gladius Capital Management LP holds 70.00K shares of ABBV (ABBVIE INC), valued at $18.31M, representing 1.30% of its reported portfolio and ranking #19.

Has Gladius Capital Management LP been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Gladius Capital Management LP increased its position in ABBV. The position peaked in Q3 2026 at 70.00K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.